Background: Mivacurium is considered a relaxant suitable for tracheal intubation in children due to its rapid onset. We compared the neuromuscular effects of mivacurium, with and without priming, in children under-going elective surgery during halothane anesthesia. Methods: Forty pediatric patients (2-10 yr, ASA class I) were randomly assigned into 2 groups and studied under halothane anesthesia. The non-priming group (n=20) received mivacurium 0.25 mg/kg, and the priming group (n=20) received a priming dose of mivacurium 0.025 mg/kg, followed by an intubating dose of 0.225 mg/kg 3 min later. Thenar Electromyogram responsive to supramaximal train-of-four stimulation of the ulnar nerve at 12 s intervals was used as neuromuscular monitoring. Results: The onset time in the priming group was significantly faster than in the non-priming group (1.04 min vs. 1.7 min). The mean time from injection of intubating dose to spontaneous recovery to 25%, 50% and 75% twitch were not influenced by priming technique. Side effects, such as cutaneous flushing and hypotension, were unremarkable at this dose in children. Conclusions: Priming technique can significantly accelerates the onset of mivacurium in pediatric patients under halothane anesthesia.
背景:由於mivacurium在孩童的作用起始時間較成人為快,故被認為適合直接用於插管。因此我們於行常規手術之孩童、在以halothane麻醉下,比較mivacurium在有無預先給藥的情況下,所產生神經肌肉作用的差異。方法:四十位孩童(二至十歲,ASA class I),在以halothane麻醉下,隨機均分為兩組,無預先給藥組的一組予以注射mivacunium 0.25 mg/kg,有預先給藥先接受預先劑量0.025 mg/kg,三分鐘,再注射插管劑量0.225 mg/kg。比較兩組神經肌肉作用之作用起始時間、最大阻斷效應、阻斷回復時間、插管狀況及副作用。結果:Mivacurium的作用起始時間,於有預先給藥組,較之無預先給藥組,有顯著的增快(1.04分鐘比1.7分鐘)。最大阻斷效應、阻斷回復時間及插管狀況的平均值,並不受預先給藥的影響。副作用,如表皮潮紅和低血壓,於兩組皆不明顯。結論:Halothane麻醉孩童priming給藥技術可加速mivacurium之作用起始時間。